Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo-Reference-Cited by-同舟云学术

Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo

Published:2018-04-13 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Bucher Simon,Tête Arnaud,Podechard Normand,Liamin Marie,Le Guillou Dounia,Chevanne Martine,Coulouarn Cédric,Imran Muhammad,Gallais Isabelle,Fernier Morgane,Hamdaoui Quentin,Robin Marie-Anne,Sergent Odile,Fromenty Bernard,Lagadic-Gossmann Dominique

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-24403-1.pdf

Reference81 articles.

1. Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84 (2016).

2. Puoti, C., Elmo, M.G., Ceccarelli, D. & Ditrinco, M. Liver steatosis: The new epidemic of the Third Millennium. Benign liver state or silent killer? Eur J Intern Med pii: S0953-6205(17)30268–6, https://doi.org/10.1016/j.ejim.2017.06.024 (2017).

3. Siegel, A. B. & Zhu, A. X. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 115, 5651–5661 (2009).

4. Wong, C. R., Nguyen, M. H. & Lim, J. K. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol 22, 8294–8303 (2016).

5. Noureddin, M. & Rinella, M. E. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. Clin Liver Dis 19, 361–379 (2015).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure to Benzo(a)pyrene Enhances Acetaminophen-Induced Liver Injury in Mice at Non-Hepatotoxic Doses;Scientia Pharmaceutica;2024-06-03

2. Identifying therapeutic effect of kombucha Pirdot (Saurauia vulcani Korth.) against colorectal cancer: The experimental data and in silico approach;Medicine in Microecology;2024-06

3. 3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments;Toxicology in Vitro;2024-02

4. Hepatoprotective Effects of Flavonoids against Benzo[a]Pyrene-Induced Oxidative Liver Damage along Its Metabolic Pathways;Antioxidants;2024-01-31

5. Toxicity mechanisms of biomass burning aerosols in in vitro hepatic steatosis models;Science of The Total Environment;2023-12